Suppr超能文献

导管消融或抗心律失常药物治疗后与复发性心房颤动相关的临床和社会经济因素。

Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy.

作者信息

An Jaejin, Bansal Nisha, Zheng Chengyi, Lee Ming-Sum, Wei Rong, Harrison Teresa N, Fan Dongjie, Garcia Elisha, Lidgard Benjamin, Zelnick Leila R, Singer Daniel E, Go Alan S

机构信息

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California.

Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.

出版信息

Heart Rhythm O2. 2025 Feb 21;6(5):631-640. doi: 10.1016/j.hroo.2025.02.007. eCollection 2025 May.

Abstract

BACKGROUND

Maintaining sinus rhythm after initiating rhythm control strategies in atrial fibrillation (AF) remains challenging.

OBJECTIVE

The study sought to investigate risk factors associated with AF recurrence among patients with incident AF who underwent catheter ablation or received antiarrhythmic drugs (AADs).

METHODS

We identified adults with incident AF from 2010 to 2017 who underwent catheter ablation or initiated AAD therapy from 2 U.S. healthcare systems and were followed through 2019. Using electronic health records and a validated natural language processing algorithm, we evaluated the 12-month cumulative incidence of recurrent AF and examined the associations between clinical and socioeconomic factors and AF recurrence using Fine-Gray subdistribution hazard models.

RESULTS

Among 982 patients who underwent catheter ablation and 18,025 who initiated AAD therapy, the 12-month incidence of recurrent AF was 55.5% and 62.7%, respectively, with median times to AF recurrence of 168 and 24 days, respectively. Heart failure was associated with AF recurrence after catheter ablation (adjusted hazard ratio [aHR] 1.41, 95% confidence interval [CI] 1.09-1.81) and AAD therapy (aHR 1.30, 95% CI 1.25-1.36). Low educational attainment (aHR 1.42, 95% CI 1.04-1.95) and higher low-density lipoprotein cholesterol (for ≥100 mg/dL vs 70-99 mg/dL: aHR 1.26, 95% CI 1.02-1.57) were associated with AF recurrence following catheter ablation; obesity (for body mass index ≥40 kg/m vs <25 kg/m: aHR 1.27, 95% CI 1.17-1.38), hypertension (aHR 1.08, 95% CI 1.03-1.14), and lower estimated glomerular filtration rate (for 45-59 mL/min/1.73 m vs ≥60 mL/min/1.73 m: aHR 1.08, 95% CI 1.03-1.14) were associated with AF recurrence following AAD initiation.

CONCLUSION

Heart failure, dyslipidemia, obesity, hypertension, reduced estimated glomerular filtration rate, and living in neighborhoods with low educational attainment were associated with higher risk for AF recurrence, emphasizing the importance of identifying and managing modifiable factors in AF.

摘要

背景

在心房颤动(AF)中启动节律控制策略后维持窦性心律仍然具有挑战性。

目的

本研究旨在调查接受导管消融或服用抗心律失常药物(AADs)的初发性AF患者中与AF复发相关的危险因素。

方法

我们从2个美国医疗系统中识别出2010年至2017年患有初发性AF且接受导管消融或开始AAD治疗并随访至2019年的成年人。使用电子健康记录和经过验证的自然语言处理算法,我们评估了AF复发的12个月累积发生率,并使用Fine-Gray亚分布风险模型检查了临床和社会经济因素与AF复发之间的关联。

结果

在982例接受导管消融的患者和18025例开始AAD治疗的患者中,AF复发的12个月发生率分别为55.5%和62.7%,AF复发的中位时间分别为168天和24天。心力衰竭与导管消融(校正风险比[aHR]1.41,95%置信区间[CI]1.09-1.81)和AAD治疗(aHR 1.30,95%CI 1.25-1.36)后的AF复发相关。低教育程度(aHR 1.42,95%CI 1.04-1.95)和较高的低密度脂蛋白胆固醇(≥100mg/dL与70-99mg/dL相比:aHR 1.26,95%CI 1.02-1.57)与导管消融后的AF复发相关;肥胖(体重指数≥4kg/m²与<25kg/m²相比:aHR 1.27,95%CI 1.17-1.38)、高血压(aHR 1.08,95%CI 1.03-1.14)和较低的估计肾小球滤过率(45-59mL/min/1.73m²与≥60mL/min/1.73m²相比:aHR 1.08,95%CI 1.03-1.14)与开始AAD治疗后的AF复发相关。

结论

心力衰竭、血脂异常、肥胖、高血压、估计肾小球滤过率降低以及生活在教育程度低的社区与AF复发风险较高相关,强调了识别和管理AF中可改变因素的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3648/12147619/9da3d8c58dce/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验